I followed a common pre-wedding trend... it made me infertile
The New York dietitian, who already lived a healthy lifestyle, began eating more vegetables, lean meats such as fish and chicken and started working out seven days a week, sometimes for up to three hours a day.
Donovan also began to track her food intake and made sure she did not consume more than 1,500 calories every day - significantly less than the recommended 2,400 calories needed to maintain a healthy weight.
She said: 'I got engaged and thought, "I have to get into the best shape of my life". So I kicked into overdrive.'
But while the dietitian managed to reach her goal weight well in time for her 2011 wedding, she realized the damage her strict diet had caused her years later.
Due to the lack of healthy fat, low body weight and excessive exercise, Donovan was diagnosed with functional hypothalamic amenorrhea (FHA).
FHA is described a condition that causes a woman's menstrual periods to stop due to problems with the hypothalamus - a part of the brain that regulates hormone release.
If left untreated, the condition which affects 1.62 million American women, can cause infertility and other long-term health problems, including bone density loss.
The now 39-year-old told Newsweek: 'I would exercise before work and then run after work. It was partly for stress relief, but I wasn't fueling my body properly, and that created even more stress physically.
'I was eating healthier and calculating my calories based on height. That's another misconception, that our bodies are just calculations.'
But while she being congratulated for her physique and discipline at her wedding, Donovan's body had already begun to show signs of FHA.
Initially, she thought that missing her period was a result of her discontinuing her birth control pill and as a result, decided to take it again before her wedding.
'My doctor told me it was normal post-pill amenorrhea [the absence of menstruation] and to wait three to five months. But with the wedding approaching, I went back on the pill,' she said.
However, what she did not realize was that her missing menstrual cycle was far more serious and was not going to return anytime soon - a signal she would struggle with infertility.
Over the next five years, Donovan and her husband continued to look for an answer as she underwent hormone therapies, supplements and acupuncture to bring back her menstrual cycle and reverse her infertility.
At one point, Donovan was misdiagnosed with Polycystic Ovary Syndrome - a hormonal disorder characterized by irregular periods and ovarian cysts.
She told Newsweek: 'I was told I had Polycystic Ovary Syndrome (PCOS), which is actually a common misdiagnosis when the real issue is hypothalamic amenorrhea.'
The brain's hypothalamus is known as the command center for several bodily processes and is responsible for signaling the body to release crucial reproductive hormones such as estrogen in women.
However, triggers such as excessive exercise, poor nutrition and environmental stress can cause the hypothalamus to enter 'survival mode' and stop working properly.
As a result, the organ puts certain bodily processes and functions on hold such as a regular menstrual cycle so it can focus on the more important ones such as breathing.
This can contribute to a hormonal imbalance in the body. Combined with a lack of healthy fat, a person becomes increasingly susceptible to developing FHA.
Apart from an irregular or completely missing menstrual cycle, symptoms of FHA also include low energy, vaginal dryness, low sex drive, depression, anxiety, hair loss and headaches.
Eventually, the young New Yorker was diagnosed with FHA and was told that she would need to start eating more and reduce her exercising if she wished to reverse her infertility.
By the time she turned 30, Donovan began undergoing IVF as she continued to seek answers about her condition - but failed to conceive a child after three cycles.
However, after completely scaling back her intense workouts and increasing her calorie intake, she finally became pregnant with her first son in 2016 via IVF.
As Donovan continued to breastfeed her newborn while eating more calories and exercising less, her menstrual cycle returned.
Three months later, she became pregnant again with her second son without medical intervention and the child was born in 2018.
Talking about her her weight loss journey for her wedding, she said: 'Do you just want to see a nice body - or a woman who lived, laughed and loved up until her special day?
'When I look at mine, I see a girl who was unhappy with her body, even though she worked her butt off. I was empty inside and on edge, because I wasn't eating enough.'
After spending years recovering and reversing the damage in her body, Donovan said of her eating habits: 'You can get in shape, but it doesn't have to be extreme. It shouldn't cost you your health. I want women to feel free - not stressed - around food.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
11 minutes ago
- Reuters
US FDA approves Insmed's drug as first treatment for a chronic lung disease
Aug 12 (Reuters) - The U.S. Food and Drug Administration has approved Insmed's (INSM.O), opens new tab oral drug for a type of lung disease, the company said on Tuesday, making it the first treatment for the chronic condition. Shares of the New Jersey-based drugmaker rose 6% in morning trade. Insmed's drug, branded as Brinsupri, targets non-cystic fibrosis bronchiectasis, a chronic lung condition characterized by permanently damaged airways, leading to persistent cough and excessive mucus production. The condition affects 350,000 to 500,000 adults in the U.S., according to the American Lung Association. Brinsupri works by blocking certain inflammatory enzymes in white blood cells, preventing them from becoming overactive and damaging the lungs. Earlier treatments for the condition focused on controlling symptoms by using antibiotics, surgery or devices such as flutter valves to clear the airways. Insmed's application was based on a late-stage trial involving 1,680 adult and 41 adolescent patients, with the drug significantly reducing the frequency of respiratory symptoms such as chronic cough. The drug was found to be safe and well-tolerated at the two tested doses of 10 milligrams and 25 milligrams. TD Cowen analyst Ritu Baral expects the drug to reach peak sales of $3.7 billion in the United States by 2031. Brinsupri has the potential to drive future profitability for the company, she said. Rival treatments in development for the chronic lung condition include AstraZeneca's (AZN.L), opens new tab benralizumab and Zambon's inhaled antibiotic therapy CMS I-neb. This marks the second FDA approval for Insmed following Arikayce, which the agency cleared in 2018 to treat a chronic lung infection caused by bacteria commonly found in soil and water.
Reuters
41 minutes ago
- Reuters
US FDA approves Insmed's lung disease drug
Aug 12 (Reuters) - The U.S. Food and Drug Administration has approved Insmed's (INSM.O), opens new tab oral drug for a type of lung disease, the company said on Tuesday, making it the first treatment for the chronic condition. Insmed's drug, branded as Brinsupri, targets non-cystic fibrosis bronchiectasis, a chronic lung condition characterized by permanently damaged airways, leading to persistent cough and excessive mucus production. It affects 350,000 to 500,000 adults in the U.S., according to the American Lung Association. Brinsupri works by blocking certain inflammatory enzymes in the white blood cells, preventing them from becoming overactive and damaging the lungs.
Daily Mail
41 minutes ago
- Daily Mail
Popular hair growth cream recalled over risk of 'serious injury or death from poisoning'
Officials are raising the alarm over a popular hair loss serum sold nationwide that could cause serious injury and death. Sefralls Minoxidil Hair Generation Serum, sold in amber dropper bottles for $10 on Amazon, is being recalled because it is not in child-resistant packaging. The US Consumer Product Safety Commission, which announced the recall, warned children could accidentally open and consume the minoxidil-laced fluid. Scientists say that consuming just a few ounces of minoxidil, an over-the-counter medication approved by the FDA to reverse hair loss, can cause blood vessels to become dangerously relaxed, triggering extremely low blood pressure. This can cause the heart to shut down, start beating erratically or go into heart failure, and cause death. It can also pose a serious hazard to pets if ingested. About 21,300 units of the product have been recalled and were distributed in the US from June 2024 to June 2025. No injuries or deaths have been reported to date. Guangzhou Ariel Biotech, the Chinese company behind the product, has urged customers to immediately place recalled bottles out of sight or reach of children and contact them for instructions on how to destroy the bottles. It is offering to send replacements to customers who pour the contents of the bottle into the trash, photograph it and send the image to the company. Officials said customers could identify whether their minoxidil had been recalled by whether it mentioned 'Sefralls' and 'minoxidil' on the label. The bottles sold also had a white and gold dropper and a white, black and gold label. The recall is thought to affect every bottle of Sefralls Minoxidil Hair Generation Serum sold in the US. In the recall notice on August 7, the CPSC wrote: 'The hair serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.' All bottles of minoxidil sold in the US are required to be child resistant under the 1970 Poison Prevention Packaging Act. Officials included minoxidil in the act amid mounting concerns over the risk the drug posed to small children. There are no publicly reported fatalities in the US to date among young children who accidentally consumed minoxidil. Minoxidil has exploded in popularity in recent years, alongside hair loss drug finasteride, with about 13million Americans estimated to use the drug in 2024. The US hair loss market has also surged in value, with estimates suggesting it will more than double from a value of $2.84billion to more than $5.26billion over the next decade. The drug works by boosting blood flow to the areas surrounding hair follicles, which can stimulate hair regrowth and restore hair in previously bald patches. It is formulated in low concentrations in hair loss treatments to achieve this effect safely, minimizing the risk to patients. If consumed, doctors treat patients by administering large amounts of fluids and medications to raise blood pressure. The FDA has only approved minoxidil as a drug for treating hair loss. It is at least the second recall over minoxidil being sold in non-child safe bottles in as many months, after another recall was issued in late July for Aemerry Hair Growth Serums, which also was not sold in child-resistant packaging. About 2,300 bottles of the hair growth serums were sold online at from March to June this year for about $22 each. They were sold in black-tinted bottles with droppers for dispensing the serums and navy blue labels with blue and white lettering. The front of the bottles read: 'Aemerry Clinically Proven To Help Regrow Beard 5% Minoxidil with Biotin.' No injuries or deaths have been reported to date, and consumers are being urged to throw out the bottles.
